Last reviewed · How we verify
nebulized morphine
Nebulized morphine works by releasing morphine into the lungs to provide pain relief.
Nebulized morphine works by releasing morphine into the lungs to provide pain relief. Used for Acute pain, Cough.
At a glance
| Generic name | nebulized morphine |
|---|---|
| Sponsor | University of Monastir |
| Drug class | opioid |
| Target | mu-opioid receptor |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | Phase 3 |
Mechanism of action
Morphine binds to opioid receptors in the lungs, which helps to reduce pain perception. This is achieved by activating the mu-opioid receptor, leading to a decrease in the transmission of pain signals to the brain.
Approved indications
- Acute pain
- Cough
Common side effects
- Respiratory depression
- Nausea
- Vomiting
- Dizziness
- Headache
Key clinical trials
- Nebulized Morphine in Chest Trauma Patients: A Prospective Study (PHASE3)
- Morphine for Dyspnea in Pulmonary Fibrosis (PHASE3)
- IV NSAI Versus Nebulized Morphine Analgesia for First-line Renal Colic (PHASE1)
- First Evaluation of Morphine Hydrochloride by Nebulisation in Healthy Volunteers (PHASE1, PHASE2)
- Nebulized Analgesia for Laparoscopic Appendectomy Trial (PHASE1, PHASE2)
- Titrated Versus High and Low Dose Nebulized Morphine to Reduce Pain in Emergency Settings (NA)
- Efficacy Study of Nebulized Morphine and Intravenous Morphine in Post Traumatic Pain (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- nebulized morphine CI brief — competitive landscape report
- nebulized morphine updates RSS · CI watch RSS
- University of Monastir portfolio CI